Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Yabao Pharmaceutical
Yabao Pharmaceutical
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Yabao Pharmaceuticals and Salus Pharma announce strategic partnership for generic drugs
Yabao Pharmaceuticals is a leading Chinese pharmaceutical company with fully integrated development, manufacturing and commercialisation capabilities
Research & Development
Yabao and Sciecure Pharma to develop, manufacture and commercialise generics for US and China
No financial terms are released
Research & Development
Yabao Pharmaceuticals enters second collaboration with Eli Lilly
To develop Lilly's sodium-glucose linked transporter inhibitor (SGLT1) molecule which has completed pre-clinical development
Research & Development
Yabao Pharmaceuticals and University of South Australia announce new drug discovery laboratory
New collaboration will focus on the development of new treatments for cancer
Subscribe now